Xeris Biopharma (XERS) Daily Trading Summary
- Closing price (24 Feb 2026, 02:46 AM CET): USD 10.20
- Price change: -3.05 % (down 0.31 USD)
- Volume traded in last 24 hours: USD 18.1 million
- Total shares outstanding: 182.3 million
- Market capitalization: USD 2.0 billion
- Simple moving average (200 days): USD 7.40
- 52‑week high: USD 11.42 (19 Oct 2026)
- 52‑week low: USD 5.25 (25 Mar 2026)
Since the close of the previous month, XERS has risen 23.6 %. The stock’s current trading price places it above its 200‑day moving average, indicating a recent upward trend. However, the recent intraday decline suggests a short‑term reversal.
Comparative Performance (Last 24 Hours)
| Ticker | Trade Direction | Current Price (USD) | Market Cap (USD) | P/E Ratio |
|---|---|---|---|---|
| PGEN | Down 3.18 % | 6.19 | 2.4 bn | – |
| HTO | Up 4.41 % | 58.90 | 2.4 bn | 19.85 |
| NLST | Down 2.88 % | 5.86 | 2.3 bn | 2,338.46 |
| BBT | Up 6.96 % | 30.07 | 2.4 bn | 14.64 |
| SMR | Down 1.43 % | 5.38 | 2.4 bn | – |
Company Overview
Xeris Biopharma Holdings, Inc. is a holding company that develops and commercializes liquid‑stable injectable formulation platforms. The company operates through its subsidiaries to deliver innovative drug delivery solutions across the global healthcare market.
